Immunotherapy with allergens

Area of Science:

• Immunology
• Allergy and Clinical Immunology

Background:

• Allergen immunotherapy (AIT) is an established treatment for allergic asthma, allergic rhinitis, and hymenoptera venom hypersensitivity.
• The precise mechanisms by which AIT improves clinical symptoms remain incompletely understood.

Purpose of the Study:

• To elucidate the immunological mechanisms underlying the efficacy of allergen immunotherapy.
• To understand how AIT modulates the immune response to allergens.

Main Methods:

• Review of existing studies on allergen immunotherapy.
• Analysis of immunological markers including specific IgE, cytokine profiles, and cellular responses.

Main Results:

• AIT induces a shift in the cytokine milieu from T(H)2 to T(H)1 predominance.
• This shift leads to decreased interleukin-4, reduced eosinophil recruitment and activation, and diminished mast cell proliferation.
• Consequently, allergen exposure elicits a less potent inflammatory cell response and reduced target organ hyperreactivity.

Conclusions:

• Allergen immunotherapy is effective but carries risks, necessitating careful consideration against medical management.
• Optimizing allergen concentrations in standardized extracts is crucial for controlling adverse events and improving treatment safety.